These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 15467034)

  • 41. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
    Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
    Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
    Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
    Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
    Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
    Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Latent membrane protein 1 of Epstein-Barr virus regulates death-associated protein kinase 1 in lymphoblastoid cell line.
    Lee CW; Leu SJ; Tzeng RY; Wang SF; Tsai SC; Sun KH; Chen RH; Huang JC
    Virology; 2011 Apr; 413(1):19-25. PubMed ID: 21353277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma.
    Khan SB; Maududi T; Barton K; Ayers J; Alkan S
    Br J Haematol; 2004 Apr; 125(2):156-61. PubMed ID: 15059137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas.
    Lee RK; Cai JP; Deyev V; Gill PS; Cabral L; Wood C; Agarwal RP; Xia W; Boise LH; Podack E; Harrington WJ
    Cancer Res; 1999 Nov; 59(21):5514-20. PubMed ID: 10554028
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G; Gekeler V; Leja A; Beckers T; Boehm M
    Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
    Portis T; Longnecker R
    Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
    Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG
    Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined effects of histone deacetylase inhibitor and rituximab on non-Hodgkin's B-lymphoma cells apoptosis.
    Zhao WL; Wang L; Liu YH; Yan JS; Leboeuf C; Liu YY; Wu WL; Janin A; Chen Z; Chen SJ
    Exp Hematol; 2007 Dec; 35(12):1801-11. PubMed ID: 17681667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
    Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
    Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
    Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
    Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K
    Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors.
    Feng WH; Israel B; Raab-Traub N; Busson P; Kenney SC
    Cancer Res; 2002 Mar; 62(6):1920-6. PubMed ID: 11912175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.